SHCS

Swiss HIV Cohort Study

& Swiss Mother and Child HIV Cohort Study

3. Antiretroviral treatment

3. Antiretroviral treatment

3.1: Treatment status at recruitment, by CD4 and year 

3.2: Treatment status at recruitment, by HIV viral load and year

3.3: Treatment status of participants under follow-up, by CD4 and year

3.4: Treatment status of participants under follow-up, by HIV viral load and year

3.5: Participants under treatment by first, second and other regimen, median of the duration (days)

3.6: The most frequent combinations: reference 1st January 2023
3.6.1 The most frequent combinations: reference 1st July 2022

3.7: The most frequent initial regimens started in 2022
3.7.1 – 3.7.5.: The most frequent initial regimens started in 2021 to 2017

3.8: The most frequent treatment switches in 2022
3.8.1 – 3.8.5.: The most frequent treatment switches in 2021 to 2017

3.9 The most frequent treatment switches in 2022: from – > to

3.10.1 – 3.10.6.: The five most frequently discontinued regimens by reason, number in 2017 to 2022